What is Wedbush’s Forecast for DAWN Q1 Earnings?
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Equities researchers at Wedbush dropped their Q1 2025 EPS estimates for Day One Biopharmaceuticals in a research note issued on Wednesday, February 26th. Wedbush analyst R. Driscoll now forecasts that the company will earn ($0.43) per share for the quarter, down from their previous estimate of […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Free Report) – Equities researchers at Wedbush dropped their Q1 2025 EPS estimates for Day One Biopharmaceuticals in a research note issued on Wednesday, February 26th. Wedbush analyst R. Driscoll now forecasts that the company will earn ($0.43) per share for the quarter, down from their previous estimate of […]
